Name: UMIN ID:
Unique ID issued by UMIN | UMIN000016255 |
---|---|
Receipt number | R000018856 |
Scientific Title | Phase II clinical study of nab-PTX/CBDCA (administer 3-weeks on / 1-week off) for patients with clinical stage IIIB/IV or recurrent NSCLC |
Date of disclosure of the study information | 2015/01/19 |
Last modified on | 2018/07/22 14:35:49 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/01/18 19:57:40 | ||
2 | Update | 2018/07/22 14:35:49 | Recruitment status |